CVS HEALTH Corp — Director's Dealing 2017

Mar 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-03-21

Reporting Person: Brennan Troyen A (EVP and Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-21	Common Stock	M	16637	$45.07	Acquired	94309.059	Direct
2017-03-21	Common Stock	S	16637	$78.73	Disposed	77672.059	Direct
2017-03-21	Common Stock	S	7212	$78.73	Disposed	70460.059	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-21	Stock Option	$45.07	M	16637	Disposed	2019-04-02	Common Stock (16637)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (restricted)	36572	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$54.53	2020-04-01	Common Stock (23604)	23604	Direct
Stock Option	$74.29	2021-04-01	Common Stock (54550)	54550	Direct
Stock Option	$102.26	2022-04-01	Common Stock (47937)	47937	Direct
Stock Option	$104.82	2023-04-01	Common Stock (53772)	53772	Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.30 and $79.00 per share.

F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.32 and $79.00 per share.

F4: Option became exercisable in four equal annual installments, commencing 4/2/2013.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2014.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2015.

F7: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F8: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.